(FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|
Operating Cash Flow (Indirect Method) | |||
Cash flow from continuing operating activities | 35.57%-70.12K | -37.23%-108.84K | -79.32K |
Net income from continuing operations | 259.88%32.99K | 50.84%-20.63K | ---41.96K |
Depreciation and amortization | 127.24%1.39K | --613 | --0 |
Change In working capital | -17.65%-104.5K | -137.81%-88.83K | ---37.35K |
-Change in receivables | ---118.67K | ---- | --0 |
-Change in inventory | ---- | ---- | --0 |
-Change in payables and accrued expense | ---- | ---- | --0 |
-Change in other current assets | 114.62%5.27K | 59.72%-36.04K | ---89.47K |
-Change in other current liabilities | 116.85%8.9K | -201.28%-52.79K | --52.12K |
Cash from discontinued investing activities | |||
Operating cash flow | 35.57%-70.12K | -37.23%-108.84K | ---79.32K |
Investing cash flow | |||
Cash flow from continuing investing activities | -614.05%-26.47K | -3.71K | 0 |
Net PPE purchase and sale | ---- | ---3.71K | --0 |
Net investment purchase and sale | ---26.47K | ---- | --0 |
Cash from discontinued investing activities | |||
Investing cash flow | -614.05%-26.47K | ---3.71K | --0 |
Financing cash flow | |||
Cash flow from continuing financing activities | 34.25%172.69K | 1,275.29%128.64K | -10.95K |
Net common stock issuance | 34.25%172.69K | 1,275.29%128.64K | ---10.95K |
Cash from discontinued financing activities | |||
Financing cash flow | 34.25%172.69K | 1,275.29%128.64K | ---10.95K |
Net cash flow | |||
Beginning cash position | 4,369.17%16.67K | -99.61%373 | --95K |
Current changes in cash | 373.12%76.1K | 117.82%16.09K | ---90.26K |
Effect of exchange rate changes | 4,025.00%8.75K | 104.85%212 | ---4.37K |
End cash Position | 508.97%101.52K | 4,369.17%16.67K | --373 |
Free cash flow | 37.70%-70.12K | -41.90%-112.55K | ---79.32K |
Currency Unit | USD | USD | USD |
No Data